BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10337659)

  • 1. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
    Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
    Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleolar organizer regions distribution in fine needle aspiration cytological smears from breast lesions.
    Hasnan J; Jayaram G
    Malays J Pathol; 1996 Jun; 18(1):35-41. PubMed ID: 10879223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AgNOR analysis of atypical ductal hyperplasia and intraductal carcinoma of the breast.
    Guski H; Hufnagl P; Kaufmann O; Krause M; Winzer KJ
    Anal Quant Cytol Histol; 2000 Jun; 22(3):206-12. PubMed ID: 10872036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardized demonstration of silver-stained nucleolar organizer regions-associated proteins in archival oral squamous cell carcinomas and adjacent non-neoplastic mucosa.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    Mod Pathol; 1997 Feb; 10(2):98-104. PubMed ID: 9127314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between cancerous and normal hyperplastic lobules in breast lesions.
    Slater M; Danieletto S; Pooley M; Cheng Teh L; Gidley-Baird A; Barden JA
    Breast Cancer Res Treat; 2004 Jan; 83(1):1-10. PubMed ID: 14997049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolar organizer regions in human breast cancer.
    Roller E; Fritz P; Wicherek C; Klumpp B; Lauinger J; Mischlinski A; Wanner B; Schumacher K
    Zentralbl Pathol; 1993 Aug; 139(3):195-9. PubMed ID: 8218120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic relevance of silver stained nucleolar organizer region (AgNORs) in benign and malignant breast lesions.
    Agarwal PK; Mehrotra A; Chandra T
    Indian J Exp Biol; 1995 Oct; 33(10):715-20. PubMed ID: 8575800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphorylated form of connexin43 is up-regulated in breast hyperplasias and carcinomas and in their neoformed capillaries.
    Gould VE; Mosquera JM; Leykauf K; Gattuso P; Dürst M; Alonso A
    Hum Pathol; 2005 May; 36(5):536-45. PubMed ID: 15948121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
    Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
    J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argyrophilic nucleolar organiser regions (AgNORs) in breast lesions.
    Dasgupta A; Ghosh RN; Sarkar R; Laha RN; Ghosh TK; Mukherjee C
    J Indian Med Assoc; 1997 Sep; 95(9):492-4. PubMed ID: 9529579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G; Lawton TJ; Rebbeck TR; LiVolsi VA; Zhang PJ
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of silver-stained nucleolar organizer region associated proteins (AgNORs) after wet autoclave pretreatment in breast carcinoma: correlation to tumor stage and long-term survival.
    Ofner D; Bier B; Heinrichs S; Berghorn M; Dünser M; Hagemann HA; Langer D; Böcker W; Schmid KW
    Breast Cancer Res Treat; 1996; 39(2):165-76. PubMed ID: 8872325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of fixation and preparation on the AgNOR distribution in routinely processed breast cancer specimens.
    Biesterfeld S; Ruoss E; Hufnagl P; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):41-8. PubMed ID: 7515672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic value of AgNORs in breast cancer].
    Aubele M; Auer G; Jütting U
    Zentralbl Pathol; 1994 Mar; 140(1):55-60. PubMed ID: 7515674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic utility of p75 neurotrophin receptor (p75NTR) as a marker of breast myoepithelial cells.
    Popnikolov NK; Cavone SM; Schultz PM; Garcia FU
    Mod Pathol; 2005 Dec; 18(12):1535-41. PubMed ID: 16258511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast.
    Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G
    J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AgNOR counts and their combination with flow cytometric analyses and clinical parameters as a prognostic indicator in breast carcinoma.
    Rzymowska J
    Tumori; 1997; 83(6):938-42. PubMed ID: 9526588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK; Govil A
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.